Sign in
4/A

Changes in Ownership

NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-012650

CHIEF FINANCIAL OFFICER bought 16,337 shares at an average $1.11 ($18,215)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
VAN VOORHEES SETH CHIEF FINANCIAL OFFICER 2022-11-25 Purchase +8,716 $1.12 $9,762 8,716 D
VAN VOORHEES SETH CHIEF FINANCIAL OFFICER 2022-11-25 Purchase +600 $1.10 $660 9,316 D
VAN VOORHEES SETH CHIEF FINANCIAL OFFICER 2022-11-25 Purchase +7,021 $1.11 $7,793 16,337 D
Open-market purchases · 16,337 sh · avg $1.11 · $18,215
Loading xslF345X03/form4a-12192022_121206.xml…